The study investigates the effects of the Jeduxiaoliu formula (JDXLF) on lymphoma, aiming to understand its mechanism of action in treating this common blood cancer.
Using RNA-Seq and various assays, researchers found that JDXLF significantly affects lymphoma cell proliferation, induces apoptosis, and alters gene expression linked to cancer cell death.
In mouse models, JDXLF demonstrated a notable tumor-shrinking effect, suggesting its potential as a therapeutic option for lymphoma treatment and emphasizing the need for further research.